Abstract:Mutations in the transforming growth factor beta type II receptor (TGF beta RII) have been identified in human cancers, which suggests a causal role for the loss of TGF-beta RII in cancer development. To directly test this in vivo, we have generated transgenic mice expressing a dominant negative TGF-beta RII (Delta beta RII) in the epidermis, using a truncated mouse loricrin promoter (Rn). ML.Delta beta RII transgenic exhibited a thickened skin due to epidermal hyperproliferation. When these mice were subjected to a standard two-stage chemical carcinogenesis protocol, they exhibited an increased sensitivity, with an earlier appearance and a 2-fold greater number of papillomas than control mice. In addition, papillomas in control mice regressed after termination of 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment; whereas ML.Delta beta RII papillomas progressed to carcinomas, Furthermore, TPA promotion alone induced papilloma formation in ML.Delta beta RII mire, which suggests an initiating role for Delta beta RII in skin carcinogenesis. ML.Delta beta RII tumors also exhibited increased neovascularization and progressed to metastases, although the primary tumors were still classified as carcinoma in situ or well-differentiated carcinomas, Increased expression of vascular endothelial growth factor, an angiogenesis factor, and decreased expression of thrombospondin-1, an angiogenesis inhibitor, were also observed in ML.Delta beta RII tumors, The increased angiogenesis correlated with elevated endogenous TGF-beta 1 in ML.Delta beta RII tumors, These data provide in vivo evidence that inactivation of TGF-beta RII accelerates skin carcinogenesis at both earlier and later stages, and increased angiogenesis is one of the important mechanisms of accelerated tumor growth and metastasis.

Conditional Expression Of The Dominant-Negative Tgf-Beta Receptor Type Ii Elicits Lingual Epithelial Hyperplasia In Transgenic Mice

The Interactions of TGF-beta Signalling Pathway and Jagged2/Notch1 Pathway Induce Acanthosis in Lingual Epithelia.

Local Microenvironment Provides Important Cues For Cell Differentiation In Lingual Epithelia

Concerted Action of TGF-beta 1 and Its Type II Receptor in Control of Epidermal Homeostasis in Transgenic Mice.

Blocking Transforming Growth Factor Beta Signaling In Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated With Increased Angiogenesis

[Cross-Talk Between Notch1 and Epidermal Growth Factor Receptor Signalling in Regulating Cell Proliferation of Human Tongue Squamous Carcinoma Cells].

TGF-β1 Inhibits Growth and Branching Morphogenesis In Embryonic Mouse Submandibular and Sublingual Glands in Vitro: (Salivary glands/extracellular matrix/epithelium/mesenchyme/organ culture)

Study on the Effects of Overexpression of Exogenous Notch1 in Tongue Squamous Cell Carcinoma Cells on Cell Growth and Expression of Epidermal Growth Factor Receptor in Vitro

Expression of transforming growth factor beta receptor during mouse submandibular gland development

Overexpression of Transforming Growth Factor Beta1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation.

Overexpression of Transforming Growth Factor Type III Receptor Restores TGF-β1 Sensitivity in Human Tongue Squamous Cell Carcinoma Cells

Development of Gene-Switch Transgenic Mice That Inducibly Express Transforming Growth Factor Beta 1 in the Epidermis

Expression of Transforming Growth Factor (TGF)-.BETA.1 and Its Type I and Type II Receptors in Carcinoma and Leukoplakia of the Tongue: Immunohistochemical and Immunoelectron Microscopic Studies.

A Tgf Beta-Smad4-Fgf6 Signaling Cascade Controls Myogenic Differentiation And Myoblast Fusion During Tongue Development

NTPDase2+ Cells Generate Lingual Epithelia and Papillae.

Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma.

Latent Tgf Beta 1 Overexpression In Keratinocytes Results In A Severe Psoriasis-Like Skin Disorder

Downregulation of TGF-beta Receptor Types II and III in Oral Squamous Cell Carcinoma and Oral Carcinoma-Associated Fibroblasts.

The transcription factor BMI1 increases hypoxic signaling in oral cavity epithelia

Upregulation of PTEN Suppresses Invasion in Tca8113 Tongue Cancer Cells Through Repression of Epithelial–mesenchymal Transition (EMT)

Expression of Transforming Growth Factor-β1/Inducible Nitric Oxide Synthase in Tca8113 Cells